Pricing Log in Create free account
Friday 6 November 2026 Export STE’s income statement to Excel — free account

STERIS plc

STE Healthcare Medical Devices

STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.

Revenue
+8.79%
EPS
+12.8%
Free cash flow
+43.6%
Total debt
−0.21%

Quarter to September 2026, against a year earlier

252.70 1.42 −0.56%
Market cap
$24.8B
P/E
30.0×
Fwd P/E
25.1×
Dividend yield
1.02%
F-score
9/9
Altman Z
5.10
Beneish M
−2.68
Dividend safety
86/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Valuation Filings

STERIS plc 10-Q filed Nov 5, 2026

Fiscal Q2 2027 · Period ended Sep 30, 2026 · Filed · accepted 4:04 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors
Previous quarter Same quarter last year

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Aug 7, 2026: 25 added · 13 removed · 58 modified; 11 with only figures updated

  1. Modified · Financial Measures

    In the following sections of the MD&A, we may, at times, refer to a financial measuresmeasure that areis not required to be presented in the consolidated financial statements under accounting principles generally accepted in the United States ("U.S. GAAP"). We sometimes use the following financial measuresmeasure in the context of this report: backlog and debt-to-total . We define backlog as the amount of unfilled capital equipment purchase orders (excluding freight) at a point in time. We define these use this figure as a measure to assist in the projection of short-term financial measures as follows:results and inventory requirements.

95 more changes in this Item, word by word, in Powerpack.